Application no. and date | 01271216.2 (espacenet) (Federated) (European Patent Register), 20011212 | Patent/reg. no. and date | DK/EP 1345598, 20070905 | Publication date | 20030924 | Priority no. and date | GB 0030845, 20001218 | EP pub. no. and date |
EP 1345598 20030924 | Effective date | | Applicant/owner | SMITHKLINE BEECHAM PLC, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | P80705561DK00E | Inventor | CHAPMAN, Gayle,
c/o GlaxoSmithKline, New Frontiers Science Park South,
Third Avenue
Harlow,
Essex CM19 5AW, GB, VINSON, Mary,
c/o GlaxoSmithKline, New Frontiers Science Park South,
Third Avenue
Harlow,
Essex CM19 5AW, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/427 (2006.01) , A61P 25/18 (2006.01) , A61P 25/24 (2006.01) | Title | Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser | Int. application no. | GB2001005488 | Int. publication no. | WO2002049626 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|